Publication | Open Access
An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
44
Citations
33
References
2013
Year
Cancer ImmunosurveillanceLimited Galectin-1 ExpressionImmunologyHepatocellular Carcinoma CellsImmune Checkpoint InhibitorAntigen ProcessingAntibody EngineeringEpcam/cd3 Bispecific AntibodyImmunotherapyMedicineCell BiologyTumor MicroenvironmentCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1